| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |